Company intelligence / Profile preview

BioTeke

Wuxi, Jiangsu, China

Ownership: Private
Development stage: Commercial

Overview

BioTeke develops and manufactures molecular diagnostic instruments and rapid detection kits with ISO13485 certification. Its products include automated nucleic acid extractors, PCR machines/reagents/kits for viral/bacterial pathogen detection—including COVID‑19—and various rapid antigen/antibody test kits. The company holds multiple patents and software copyrights.

No clinical trial results are reported as the company focuses on research/diagnostic tools rather than therapeutics.

Therapeutic areas: OtherWomen's HealthInfectious Diseases
Modalities: DeviceReagent kit (for molecular diagnostics)Small molecule (as part of reagent chemistry)Protein (as part of extraction kits)Nucleic acid-based diagnostics (PCR reagents and kits)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on BioTeke.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioTeke.

Explore the full profile